The Department-related Parliamentary Standing Committee on Chemicals and Fertilizers has flagged under-utilisation of allocations in some schemes of the Department of Pharmaceuticals. The issue matters because pharmaceutical-industry support schemes affect domestic manufacturing capacity, supply-chain resilience, and the pace of industrial policy execution.

The Department of Pharmaceuticals says it has taken corrective measures to improve fund utilisation in production-linked incentive schemes, bulk drug parks, and related initiatives. The parliamentary observation did not extend to the schemes of the Department of Fertilizers or the Department of Chemicals & Petrochemicals.

What happened now

The committee observed that some allocations under the Department of Pharmaceuticals were not being fully used. In response, the Department of Pharmaceuticals has described a set of corrective actions intended to improve the pace of implementation and the absorption of budgeted funds.

Corrective measures announced by the Department of Pharmaceuticals

Stronger monitoring and fund-flow control

Related current affairs